Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 361
Gene Symbol: AQP4
AQP4
0.100 GeneticVariation group BEFREE The NMO patients with AQP4 (-) showed higher prevalence of BL, ITL, and similar spinal cord lesion length, compared to AQP4 (+), and demonstrated deep grey matter atrophy, suggesting an intermediate phenotype between that of typical MS and NMO. 28427704 2017
Entrez Id: 361
Gene Symbol: AQP4
AQP4
0.100 GeneticVariation group BEFREE We aimed to evaluate the utility of the recently described brain lesion distribution criteria to differentiate multiple sclerosis (MS) from aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis (MOG-EM) at disease onset in an Asian cohort. 29512413 2019
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.060 GeneticVariation group BEFREE This study suggests that GKRS alone could be considered for patients treated with EGFR-TKIs who have a stable systemic disease status and 3 or fewer brain lesions. 28074321 2017
Entrez Id: 4340
Gene Symbol: MOG
MOG
0.060 GeneticVariation group BEFREE <b>Conclusions:</b> Seizures and encephalopathy are not rare in MOG encephalomyelitis, and are commonly associated with cortical and subcortical brain lesions. 31080435 2019
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.060 GeneticVariation group BEFREE DCR within brain lesions in patients with activating EGFR mutations was 80% (1 PR+3 SDs), compared with 25% (1 SD) in patients with negative EGFR mutation. 22391431 2013
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.050 GeneticVariation group BEFREE Identification of tuberous sclerosis complex (TSC) gene mutations has fostered understanding of how brain lesions in TSC are formed. 10534239 1999
Entrez Id: 7248
Gene Symbol: TSC1
TSC1
0.050 GeneticVariation group BEFREE Histopathologic similarities between MCDs and dysplastic brain lesions in the autosomal inherited neurocutaneous phacomatosis tuberous sclerosis (TSC), which affects the TSC1 and/or TSC2 genes, suggest common pathogenetic mechanisms. 16042315 2005
Entrez Id: 889
Gene Symbol: KRIT1
KRIT1
0.040 GeneticVariation group BEFREE An additional unrelated sporadic subject with brain lesions compatible with CCM as well as vascular skin findings suggesting the blue rubber bleb nevus (BRBN) syndrome has no mutation detected in the CCM1 gene. 11959162 2002
Entrez Id: 7249
Gene Symbol: TSC2
TSC2
0.040 GeneticVariation group BEFREE Herein, we studied histopathological and molecular changes in brain lesions of the Eker rat model carrying germline mutation of the tsc2 gene, predisposed to multiple neoplasias. 31820275 2020
Entrez Id: 7249
Gene Symbol: TSC2
TSC2
0.040 GeneticVariation group BEFREE Histopathologic similarities between MCDs and dysplastic brain lesions in the autosomal inherited neurocutaneous phacomatosis tuberous sclerosis (TSC), which affects the TSC1 and/or TSC2 genes, suggest common pathogenetic mechanisms. 16042315 2005
Entrez Id: 3456
Gene Symbol: IFNB1
IFNB1
0.040 GeneticVariation group BEFREE IFNB-1b should not be administered to demyelinating patients with genetic and clinical characteristics mimicking NMO such as HLA DPB1*0501 allele, longitudinally extensive spinal cord lesion, blindness and CSF pleocytosis even if they have symptomatic cerebral lesions as typically seen in MS. 17125797 2007
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.030 GeneticVariation group BEFREE Despite being incomplete disease models, transgenic mice expressing CADASIL-associated NOTCH3 mutations, have provided important insights into specific aspects of CADASIL pathogenesis, including the functional significance of disease-linked mutations and the earliest pathological events that initiate brain lesions. 20967782 2011
Entrez Id: 6567
Gene Symbol: SLC16A2
SLC16A2
0.030 GeneticVariation group BEFREE We describe brain lesions in a patient with a monocarboxylate transporter 8 mutation. 16227048 2005
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.030 GeneticVariation group BEFREE Heritability estimates in CADASIL suggest a strong modifying influence of genetic factors distinct from the causative NOTCH3 mutation on the amount of ischemic brain lesions. 17008614 2006
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.030 GeneticVariation group BEFREE A single nucleotide polymorphism (SNP), rs1800795, in the promoter region of the interleukin-6 (IL6) gene has been implicated in the pathogenesis of CP by mediating IL-6 protein levels in amniotic fluid and cord plasma and within brain lesions. 24314052 2013
Entrez Id: 8163
Gene Symbol: CDR3
CDR3
0.030 GeneticVariation group BEFREE To better understand the nature of the T cell response in this disease, we analyzed TCR expression in the brain lesions using PCR for quantitative assessment of TCRBV gene transcripts, together with size and sequence analysis of the third complementarity-determining region (CDR3) of the dominant TCR rearrangements. 9013988 1997
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 GeneticVariation group BEFREE Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. 10864599 2000
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 GeneticVariation group BEFREE To examine the association between apolipoprotein E (ApoE) genotype and visibility of traumatic brain lesions during the first year after traumatic brain injury (TBI). 18236205 2007
Entrez Id: 6962
Gene Symbol: TRBV20OR9-2
TRBV20OR9-2
0.020 GeneticVariation group BEFREE To evaluate the role of candidate genes in the susceptibility to multiple sclerosis (MS) and describe the role of T-cell receptor (TCR) gene rearrangements in the MS brain lesion in identifying a major target of the immune response in this disease. 8230601 1993
Entrez Id: 5354
Gene Symbol: PLP1
PLP1
0.020 GeneticVariation group BEFREE In order to gain mechanistic insights into multiple sclerosis (MS) pathogenesis, we utilized a multi-dimensional approach to test the hypothesis that mutations in myelin proteins lead to immune activation and central nervous system autoimmunity in MS. Mass spectrometry-based proteomic analysis of human MS brain lesions revealed seven unique mutations of PLP1; a key myelin protein that is known to be destroyed in MS. 28191734 2017
Entrez Id: 5354
Gene Symbol: PLP1
PLP1
0.020 GeneticVariation group BEFREE The observation of degenerative brain lesions occurring before the onset of subcortical myelination suggests that the PLP1 gene has a more complex role in human brain development, exceeding its structural function in myelin formation. 22511562 2012
Entrez Id: 3417
Gene Symbol: IDH1
IDH1
0.010 GeneticVariation group BEFREE In summary, we report here the real-time PCR/fluorescence melting curve analysis assay that provides rapid and sensitive detection of IDH mutations in formalin-fixed, paraffin-embedded tissues, and is therefore useful as a powerful adjunct diagnostic tool for refining histopathological diagnosis of brain lesions and guiding patient management. 20431032 2010
Entrez Id: 10814
Gene Symbol: CPLX2
CPLX2
0.010 GeneticVariation group BEFREE Correspondingly, in Cplx2 -null mutant mice, prominent cognitive loss of function was obtained only in combination with a minor brain lesion applied during puberty, modeling a clinically relevant environmental risk ("second hit") for schizophrenia. 20819981 2010
Entrez Id: 5624
Gene Symbol: PROC
PROC
0.010 GeneticVariation group BEFREE Remarkably, mAPC(PS/N329Q) limited cerebral ischemic injury and reduced brain lesion volume significantly more effectively than mAPC(PS). 26084674 2015
Entrez Id: 7173
Gene Symbol: TPO
TPO
0.010 GeneticVariation group BEFREE Therefore, cognitive disturbance and visual-spatial deficits in MSA-C might not be due to cerebellar lesions only as is widely believed but also involve cerebral lesions. 27878764 2017